BIOVERATIV INC
Summary
Bioverativ is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 8.49 B
Avg. Deal Size£ 4.24 B
All rights reserved. Copyright © 2025 Datasite
